reports
Evelo Biosciences Announces Top-Line Results From its Phase 2 Clinical...
Evelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate Psoriasis - Primary endpoint was not achieved – - Company exploring strategic alternatives and partnering opportunities for EDP1815 and its SINTAX platform - CAMBRIDGE, Mass., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO) (“Evelo” or the “Company”), a clinical stage biotechnology company developing a novel platform of orally delivered inflammation-resolving medicines acting on the small intestinal axis (SINTAX), today announced top-line results from its Phase 2...
PFSweb, Inc. to be Acquired by GXO Logistics, Inc.
PFSweb, Inc. to be Acquired by GXO Logistics, Inc. - GXO Logistics to Acquire All Outstanding PFSweb Shares for $7.50 Per Share, Representing a 58% Premium to PFSW’s 20-Day VWAP - - Transaction Expected to be Completed in the Fourth Quarter of 2023 - IRVING, Texas, Sept. 14, 2023 (GLOBE NEWSWIRE) -- PFSweb, Inc. (NASDAQ: PFSW) (the “Company” or “PFSweb”) has entered into an Agreement and Plan of Merger to be acquired by GXO Logistics, Inc. (NYSE: GXO) (“GXO”), the world’s largest pure-play contract logistics provider, for an equity value of approximately $181 million. The transactio...
PFSweb Announces Results of 2023 Annual Meeting of Stockholders
PFSweb Announces Results of 2023 Annual Meeting of Stockholders IRVING, Texas, Aug. 29, 2023 (GLOBE NEWSWIRE) -- PFSweb, Inc. (NASDAQ: PFSW) (the "Company") held its Annual Meeting of Stockholders today, August 29, 2023, in Irving, Texas. All Company proposals were approved by the Company’s stockholders, including: the election of six directors; compensation of the Company’s named executive officers on a non-binding, advisory basis; an amendment to the Rights Agreement with Computershare Inc.; an amendment to the Company's 2020 Stock and Incentive Plan to increase the number of shares of...
Evelo Biosciences Announces Second Quarter Financial Results and Recen...
Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights – EDP2939 Phase 2 trial in moderate psoriasis fully enrolled with topline data expected early Q4 2023– Completed $25.5 Million Private Placement– Restructured and reduced secured debt with Horizon Technology Finance Corporation CAMBRIDGE, Mass., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO), (“Evelo” or the “Company”) a clinical stage biotechnology company developing a novel platform of orally delivered inflammation-resolving medicines acting on the small intestinal axis...
PFSweb Reports Strong Second Quarter 2023 Results
PFSweb Reports Strong Second Quarter 2023 Results Service Fee Revenue Growth Driven by Ongoing Fulfillment Demand Strength in Core Verticals Second Quarter Bookings Set New PFS Record Raising Full Year 2023 Annual Service Fee Revenue Growth Guidance to a Range of 8% to 13% IRVING, Texas, Aug. 08, 2023 (GLOBE NEWSWIRE) -- PFSweb, Inc. (NASDAQ: PFSW) (the "Company") is reporting results for the second quarter ended June 30, 2023. “We continued to support strong growth in our fulfillment services and sales bookings during the second quarter,” said Mike Willoughby, CEO of PFSweb....
PFSweb Sets Second Quarter 2023 Conference Call for Tuesday, August 8 ...
PFSweb Sets Second Quarter 2023 Conference Call for Tuesday, August 8 at 5:00 p.m. ET IRVING, Texas, Aug. 01, 2023 (GLOBE NEWSWIRE) -- PFSweb, Inc. (NASDAQ: PFSW) (the “Company”), a premier eCommerce order fulfillment provider, will hold a conference call on Tuesday, August 8, 2023 at 5:00 p.m. Eastern time to discuss its financial results for the second quarter ended June 30, 2023. The results will be reported in a press release prior to the conference call. PFSweb management will host the conference call, followed by a question-and-answer period. Date: Tuesday, August 8, 2023Time: 5:0...
- Jonathan Moreland
PFSW PFSWEB INC
MPAA MOTORCAR PARTS OF AMERICA INC.
CVGW CALAVO GROWERS INC.
AQMS AQUA METALS INC
ACTG ACACIA RESEARCH CORP. - ACACIA TECHNOLOGIES
CULP CULP INC.
ENPH ENPHASE ENERGY INC.
TTC TORO COMPANY
GHC GRAHAM HOLDINGS CO.
SCWX SECUREWORKS
CDZI CADIZ INC.
SVRA SAVARA
PMM PUTNAM MANAGED MUNICIPAL INCOME TRUST
RMCF ROCKY MOUNTAIN CHOCOLATE FACTORY INC.
SMBC SOUTHERN MISSOURI BANCORP INC.
PMO PUTNAM MUNICIPAL OPPORTUNITIES TRUST
VBIV VBI VACCINES INC/BC
CVLY CODORUS VALLEY BANCORP INC.
OXSQ OXFORD SQUARE CAPITAL
SMAR SMARTSHEET
EVLO EVELO BIOSCIENCES
NHS NEUBERGER BERMAN HIGH YIELD ST
LARK LANDMARK BANCORP INC.
ZM ZOOM VIDEO COMMUNICATIONS
BW INC.
QMCO BABCOCK & WILCOX ENTERPRISES
BDTX QUANTUM CORP /DE/
ENX BLACK DIAMOND THERAPEUTICS
EPSN INC.
ZI EATON VANCE NEW YORK MUNICIPAL BOND FUND
PASG EPSILON ENERGY LIMITED
GRIL ZOOMINFO TECHNOLOGIES INC.
ACET PASSAGE BIO
ALVR INC.
HPK MUSCLE MAKER
MAX ADICET BIO INC
CLNN ALLOVIR
NRGX HIGHPEAK ENERGY INC (A)
RMBL MEDIAALPHA
JANX INC.
TTNP CLENE INC
EFSH PIMCO ENERGY & TACTICAL CREDIT OPPORTUNITIES FUND
MTEM RUMBLEON INC
OKE JANUX THERAPEUTICS INC
TITAN PHARMACEUTICALS INC
1847 HLDGS LLC
MOLECULAR TEMPLATES
INC.
ONEOK
INC.
- Jonathan Moreland
VTNR VERTEX ENERGY INC.
SWX SOUTHWEST GAS HOLDINGS INC.
PFSW PFSWEB INC
FBIZ FIRST BUSINESS FINANCIAL SERVICES
CVGW CALAVO GROWERS INC.
APPF APPFOLIO INC CLASS A
ENPH ENPHASE ENERGY INC.
TTC TORO COMPANY
UTI UNIVERSAL TECHNICAL INSTITUTE INC.
GHC GRAHAM HOLDINGS CO.
SCWX SECUREWORKS
PMM PUTNAM MANAGED MUNICIPAL INCOME TRUST
AES THE AES CORPORATION
PMO PUTNAM MUNICIPAL OPPORTUNITIES TRUST
VST VISTRA CORP.
CVLY CODORUS VALLEY BANCORP INC.
OXSQ OXFORD SQUARE CAPITAL
SMAR SMARTSHEET
EVLO EVELO BIOSCIENCES
NHS NEUBERGER BERMAN HIGH YIELD ST
LARK LANDMARK BANCORP INC.
SPFI SOUTH PLAINS FINANCIAL
BW BABCOCK & WILCOX ENTERPRISES
SDC SMILEDIRECTCLUB
ZYME INC.
QMCO ZYMEWORKS INC.
BDTX QUANTUM CORP /DE/
EPSN BLACK DIAMOND THERAPEUTICS
ZI INC.
PASG EPSILON ENERGY LIMITED
ACET ZOOMINFO TECHNOLOGIES INC.
ALVR PASSAGE BIO
FREE INC.
MAX ADICET BIO INC
DMAC ALLOVIR
CLNN WHOLE EARTH BRANDS INC (A)
SPNT MEDIAALPHA
PFX INC.
RMBL DIAMEDICA THERAPEUTICS INC.
VERA CLENE INC
LCID SIRIUSPOINT LTD
TTNP PHENIXFIN CORP
MOVE RUMBLEON INC
OKE VERA THERAPEUTICS INC
SOL LUCID GROUP INC
EFSH TITAN PHARMACEUTICALS INC
MOVANO INC
ONEOK
INC.
RENESOLA LTD
1847 HLDGS LLC
- Jonathan Moreland
Evelo Biosciences Closes $25.5 Million Private Placement
Evelo Biosciences Closes $25.5 Million Private Placement Restructures and reduces secured debt with Horizon Technology Finance Corporation Appoints two new members and decreases size of Board of Directors CAMBRIDGE, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO) (the “Company” or “Evelo”), a clinical stage biotechnology company developing a novel platform of orally delivered inflammation-resolving medicines acting on the small intestinal axis (SINTAX), today announces that it closed the previously announced private placement, resulting in gross proceeds ...
Evelo Biosciences Announces $25.5 Million Private Placement
Evelo Biosciences Announces $25.5 Million Private Placement CAMBRIDGE, Mass., July 10, 2023 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a novel platform of orally delivered inflammation-resolving medicines acting on the small intestinal axis (SINTAX), today announced that it has entered into a securities purchase agreement with investors in a private placement to sell 11,025,334 shares of its common stock (the “Shares”) at a purchase price of $2.31 per share, which would result in gross proceeds of approximately $25.5 millio...
Evelo Biosciences Announces Reverse Stock Split Effective
Evelo Biosciences Announces Reverse Stock Split Effective – EVLO common stock expected to begin trading on a split-adjusted basis on June 30, 2023 – CAMBRIDGE, Mass., June 29, 2023 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a novel platform of orally delivered inflammation-resolving medicines acting on the small intestinal axis (SINTAX), today announced that its Board of Directors has approved a 1-for-20 reverse stock split of the Company’s common stock. The reverse stock split will become effective at 5:00 p.m. Eastern Ti...
PFSweb Announces Closing of $25 Million Asset-Based Lending Agreement
PFSweb Announces Closing of $25 Million Asset-Based Lending Agreement IRVING, Texas, June 21, 2023 (GLOBE NEWSWIRE) -- PFSweb, Inc. (NASDAQ: PFSW), a premier eCommerce order fulfillment provider, announced today the closing of a $25 million asset-based secured lending agreement with Texas Capital Bank, the lending affiliate of Texas Capital Bancshares, Inc. (NASDAQ: TCBI). Under the credit agreement, and subject to the terms set forth therein, the lenders have agreed to provide Priority Fulfillment Services, Inc., a subsidiary of PFSweb, Inc., with a $25 million revolving loan facility f...
- Jonathan Moreland
TCBI TEXAS CAPITAL BANCSHARES INC.
SBCF SEACOAST BANKING CORPORATION OF FLORIDA
RNG RINGCENTRAL INC. CLASS A
PNNT PENNANTPARK INVESTMENT
PFSW PFSWEB INC
LOB LIVE OAK BANCSHARES
HTBK HERITAGE COMMERCE CORP.
GME GAMESTOP CORP. CLASS A
GCO GENESCO INC.
DG DOLLAR GENERAL CORPORATION
CTBI COMMUNITY TRUST BANCORP INC.
CMTL COMTECH TELECOMMUNICATIONS CORP.
CLRO CLEARONE
APPF APPFOLIO INC CLASS A
AAP ADVANCE AUTO PARTS INC.
SAFT SAFETY INSURANCE GROUP INC.
UHAL AMERCO
ZUMZ ZUMIEZ INC.
PLSE PULSE BIOSCIENCES
SCWX SECUREWORKS
SNAP SNAP INC. CLASS A
DMLP DORCHESTER MINERALS L.P.
AES THE AES CORPORATION
BCBP BCB BANCORP INC.
QNBC QNB CORP.
COGT COGINT
ULBI INC.
SPFI ULTRALIFE
MRBK SOUTH PLAINS FINANCIAL
DHC MERIDIAN
JYNT DIVERSIFIED HEALTHCARE TRUST
EPSN THE JOINT
CZR EPSILON ENERGY LIMITED
RILY CAESARS ENTERTAINMENT INC
LSEA B. RILEY FINANCIAL
NRGX LANDSEA HOMES CORP (A)
PFX PIMCO ENERGY & TACTICAL CREDIT OPPORTUNITIES FUND
LFMD PHENIXFIN CORP
BVS LIFEMD
AKYA INC.
UGRO BIOVENTUS
EMO AKOYA BIOSCIENCES INC
MOVE URBAN GRO INC
CLEARBRIDGE ENERGY MLP OPPORTUNITY FUND INC.
MOVANO INC
- Jonathan Moreland
PFSweb Reports First Quarter 2023 Results
PFSweb Reports First Quarter 2023 Results eCommerce Fulfillment and Luxury Brand Demand Drive Service Fee Revenue Growth and Sales Booking Momentum, Building Upon Record 2022 Performance Recorded Strongest Q1 Fulfillment Activity Levels in Company History Reiterating Full Year 2023 Guidance of 5% to 10% Annual Service Fee Revenue Growth IRVING, Texas, May 09, 2023 (GLOBE NEWSWIRE) -- PFSweb, Inc. (NASDAQ: PFSW) (the "Company") is reporting results for the first quarter ended March 31, 2023. “In the first quarter, we carried on the momentum from our record per...
PFS Continues Expansion in the United Kingdom
PFS Continues Expansion in the United Kingdom Opening New Fulfillment Center in England in Response to Strong Demand for UK Order Fulfillment Services and Organic Growth Among Existing Clients IRVING, Texas, May 04, 2023 (GLOBE NEWSWIRE) -- PFS (NASDAQ: PFSW) (the “Company”), a premier eCommerce order fulfillment provider, has entered into an agreement for lease for a new fulfillment center in Fareham, England. The Company is poised to continue expanding in the United Kingdom (UK) as it looks to capture growing demand for eCommerce order fulfillment services in the region. Amid various...
PFSweb Sets First Quarter 2023 Conference Call for Tuesday, May 9 at 5...
PFSweb Sets First Quarter 2023 Conference Call for Tuesday, May 9 at 5:00 p.m. ET IRVING, Texas, May 01, 2023 (GLOBE NEWSWIRE) -- PFSweb, Inc. (NASDAQ: PFSW) (the “Company”), a premier eCommerce order fulfillment provider, will hold a conference call on Tuesday, May 9, 2023 at 5:00 p.m. Eastern time to discuss its financial results for the first quarter ended March 31, 2023. The results will be reported in a press release prior to the conference call. PFSweb management will host the conference call, followed by a question-and-answer period. Date: Tuesday, May 9, 2023Time: 5:00 p.m. East...
Evelo Biosciences Provides Clinical Updates
Evelo Biosciences Provides Clinical Updates – Topline Data from fourth cohort of EDP1815 Phase 2 trial in atopic dermatitis did not meet primary endpoint –– Company will focus on development of extracellular vesicles (EVs) –– First EV candidate, EDP2939, in Phase 2 moderate psoriasis study fully enrolled; data anticipated in early Q4 2023 –– Management to host conference call today at 8:30 a.m. ET – CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a novel platform of orally delivered inflammation...
- Jonathan Moreland
VNOM VIPER ENERGY PARTNERS LP
TLYS TILLYS
SF STIFEL FINANCIAL CORP.
PRTK PARATEK PHARMACEUTICALS INC
PFSW PFSWEB INC
LPCN LIPOCINE INC
KSS KOHL'S CORPORATION
DLTR DOLLAR TREE INC.
DG DOLLAR GENERAL CORPORATION
CVGW CALAVO GROWERS INC.
CEMI CHEMBIO DIAGNOSTICS INC.
AVAV AEROVIRONMENT INC.
APEI AMERICAN PUBLIC EDUCATION
AEL AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY
BFS SAUL CENTERS INC.
CIVB CIVISTA BANCSHARES
UHAL AMERCO
UNFI UNITED NATURAL FOODS INC.
SCWX SECUREWORKS
OCX ONCOCYTE
BRN BARNWELL INDUSTRIES
VBIV VBI VACCINES INC/BC
BLNK BLINK CHARGING
CSSE CHICKEN SOUP FOR THE SOUL ENTERTAINMENT INC
PRPL PURPLE INNOVATION
HHC INC.
SDC THE HOWARD HUGHES CORPORATION
ALIM SMILEDIRECTCLUB
PCB INC.
ALTG ALIMERA SCIENCES
ENX PACIFIC CITY FINANCIAL CORP
U ALTA EQUIPMENT GROUP INC.
INZY EATON VANCE NEW YORK MUNICIPAL BOND FUND
PRAX UNITY SOFTWARE INC.
PUBM INOZYME PHARMA
AMWL PRAXIS PRECISION MEDICINES
FOA PUBMATIC
AFBI AMERICAN WELL
ERAS FINANCE OF AMERICA COMPANIES INC.
MIRO AFFINITY BANCSHARES
SLG INC.
COCP ERASCA INC
MIROMATRIX MEDICAL INC
SL GREEN REALTY CORP.
COCRYSTAL PHARMA INC
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.